Substance / Medication

Etoposide phosphate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

1 trials linked to this intervention

1
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Immediate severe hypersensitivity reaction to etoposide phosphate: Case report and review of the literature.
Pringle Nicole R, Gilbar Peter J, Grewal Guranjan D · J Oncol Pharm Pract · 2022
PMID: 35037804Case Report
Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity.
Brooks Joel P, Azmy Veronica, Thompson Alison et al. · J Oncol Pharm Pract · 2020
PMID: 30885040Case Report
Severe hypersensitivity reaction to etoposide phosphate: A case report.
Cotteret Camille, Rousseau Julia, Zribi Kaouther et al. · Clin Case Rep · 2020
PMID: 32983504Case ReportFull text (PMC)
Etoposide phosphate hypersensitivity overcome using a desensitisation programme enabling optimal therapy for relapsed Hodgkin lymphoma.
Polistena P, Tran Q, Cirillo M et al. · Bone Marrow Transplant · 2017
PMID: 27797366Case Report
Successful Treatment with Etoposide Base after an Acute Hypersensitivity Reaction to Etoposide Phosphate.
Leguay Zoé, Bourneau-Martin Delphine, Pellier Isabelle et al. · Pediatr Blood Cancer · 2016
PMID: 26468691Case Report
Hypersensitivity reactions to etoposide phosphate.
Sambasivan Khrishanthne, Mahmoud Sarah, Kokache Arwa et al. · J Oncol Pharm Pract · 2014
PMID: 23740378Case Report
Anaphylactic reaction to etoposide phosphate.
Lindsay Holly, Gaynon Paul · Pediatr Blood Cancer · 2012
PMID: 22522419Case Report
Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity.
Collier Kathleen, Schink Cordula, Young Anna Mary et al. · J Oncol Pharm Pract · 2008
PMID: 18337441Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Etoposide phosphate (substance)
SNOMED CT
426891005
UMLS CUI
C0059874

Clinical Data

This intervention maps to 12 entities in the Healos knowledge graph.

12
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
1
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.